RudaCure
Seoul, South Korea
Have bachelor of science degree in Integrated bioscience and biotechnology worked in Korea institue of science and technology. Eager Clinical Developer with scientific background, currently finished managing medical device clinical trial, preparing IND submission for phase 1 in Korea, phase 2 in USA.
0861: The Analgesic Effect of RC-0165, a TRPV1 Antagonist, for Osteoarthritis Pain
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.
